首页 › 基金 › Kedalion Capital Management LLP › ABUS

Kedalion Capital Management LLP 对 ABUS 的持仓历史

ARBUTUS BIOPHARMA CORP · 医疗保健

Kedalion Capital Management LLP 在 Q3 2026 的 13F 申报中披露持有 ABUS(ARBUTUS BIOPHARMA CORP)20,168 股,市值约 US$96K,约占其申报组合的 0.00%,在其申报持仓中市值排名第 5 位。 Kedalion Capital Management LLP 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)20.17K 股
申报持仓市值$96.40K
组合权重0.00%
首次申报Q3 2026
最近变动新进
更新于2026-11-06

最后更新: 2026-11-06 · 来源: SEC EDGAR Form 13F-HR

Kedalion Capital Management LLP 对 ABUS 的持仓演变

Kedalion Capital Management LLP 于 Q3 2026 首次披露 ABUS 持仓:20,168 股(约 US$96K)。

逐季持仓明细

季度股数金额变化
Q3 2026 20.17K $96.40K 新进

关于 ABUS 与 13F 数据

ABUS(ARBUTUS BIOPHARMA CORP)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 ABUS,申报仓位最大的包括:Whitefort Capital Management, LP (US$75.8M), Two Seas Capital LP (US$38.9M), BlackBarn Capital Partners LP (US$12.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ABUS 的基金

查看 ABUS 的全部基金持有人 →

常见问题

How long has Kedalion Capital Management LLP held ABUS?

Kedalion Capital Management LLP has disclosed ABUS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Kedalion Capital Management LLP's current position in ABUS?

As of Q3 2026, Kedalion Capital Management LLP holds 20.17K shares of ABUS (ARBUTUS BIOPHARMA CORP), valued at $96.40K, representing 0.00% of its reported portfolio and ranking #5.

Has Kedalion Capital Management LLP been buying or selling ABUS?

In the latest 13F filing (Q3 2026), Kedalion Capital Management LLP newly opened its position in ABUS.

Which other funds hold ABUS?

Other major institutional holders of ABUS include Whitefort Capital Management, LP, Two Seas Capital LP, BlackBarn Capital Partners LP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.